Описание деятельности
Evolva Holding SA (formerly Arpida AG) is a Swiss synthetic biology company, internationally active in sustainable, fermentation-based approaches to ingredients for health, wellness and nutrition. Evolva uses biosynthetic and evolutionary technologies to artificially create and optimise small molecule compounds and their production routes. Evolva’s products include stevia, resveratrol, vanillin, nootkatone and saffron. Evolva is active in consumer healthcare and nutrition as well as in pharma. In both areas they have partnered projects as well as own proprietary programmes.
Правление & Наблюдательный совет
| Исполнительный директор |
| Christian Wichert |
| Правление |
| Carsten Däweritz, Anne De Vos, Astrid Schäfer, Gerhard Lobmaier, Philipp Frech |
| Наблюдательный совет |
| Stephan Schindler, Beat In-Albon, Christoph Breucker, Andreas Pfluger, Andreas Weigelt |
Данные компании
| Имя: |
Evolva Holding SA |
| Адрес: |
Duggingerstraße 23,CH-4153 Reinach |
| Телефон: |
+41-61-485-2000 |
| Факс: |
+41-61-485-2001 |
| E-mail: |
info@evolva.com
|
| Интернет: |
www.evolva.com |
| Индустрия: |
Biotechnology |
| Сектор: |
Biotechnology |
| Подсектор: |
Biotechnology |
| Конец финансового года: |
31.12 |
| Акции в свободном обращении: |
69.53% |
| Дата IPO: |
26.04.2023 |
Связи с инвесторами
| Имя: |
Doris Rudischhauser |
| IR телефон: |
+41-79-410-81-88 |
| IR-факс: |
- |
| IR e-mail: |
dorisr@evolva.com
|
